FAST

Fastenal's numbers screen as A-grade. Revenue compounded from $6.01B (FY2021) to $8.20B (FY2025), with net income tracking from $925M to $1.26B and FY2025 growth re-accelerating to +8.7% revenue and +9.4% earnings after a flattish FY2024. Margins are stable at the top of the distribution peer set (gross 45.0%, operating 20.2%, net 15.3%), ROE is a remarkable 31.9%, and the balance sheet is pristine — $277M cash against only $125M of total debt (LT $100M + current $25M, both down sharply YoY) and $3.94B of equity. Cash generation is real: $1.30B of operating cash flow comfortably funded $245M of capex and $1.00B of dividends. The MD&A's 'high-touch, high-tech' moat — ~1,600 branches, vending/onsite programs, and the Magna UT and Indianapolis ASRS consolidation — is doing what it's supposed to: taking share in a fragmented $140B+ North American industrial-supplies market.

The problem is the price. At $46.92 the stock trades at 43x FY2025 diluted EPS of $1.09 and 6.6x sales for a business whose underlying earnings growth is high single digits. That is a quality multiple, not a value one, and it leaves little margin for the macro risks management itself flags. Management spends meaningful MD&A real estate on 'elevated volatility,' 'recent imposition of new and expanded tariffs,' commodity/labor/transport disruption, FX, and 'the risk of a global or regional economic recession' — all of which hit Fastenal's manufacturing-heavy end market first. They explicitly note the ultimate impact 'cannot be predicted at this time' even as they try to maintain 'price/cost neutrality.'